Predicting pathological response and overall survival in locally advanced gastric cancer patients undergoing neoadjuvant chemotherapy: the role of PET/computed tomography.

Güç, Zeynep Gülsüm; Turgut, Bülent; Avci, Arzu; Cengiz, Fevzi; Eren Kalender, Mehmet; Alacacioglu, Ahmet

Güç, Zeynep Gülsüm; Turgut, Bülent; Avci, Arzu; Cengiz, Fevzi; Eren Kalender, Mehmet; Alacacioglu, Ahmet.

Affiliation

Güç ZG; Departments of Medical Oncology.
Turgut B; Nuclear Medicine.
Avci A; Pathology.
Cengiz F; General Surgery, Izmir Katip Celebi University, Ataturk Training and Research Hospital, Izmir, Turkey.
Eren Kalender M; Departments of Medical Oncology.
Alacacioglu A; Departments of Medical Oncology.

Nucl Med Commun ; 43(5): 560-567, 2022 May 01.

Article de En | MEDLINE | ID: mdl-35045553

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'estomac / Traitement néoadjuvant Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Nucl Med Commun Année: 2022 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google